The general public will subscribe 6.25 million shares, 25 percent of the total offer size of BF Biosciences IPO on October 2nd and 3rd at the strike price of Rs 77.
The general public can subscribe the IPO on 2nd and 3rd October from 9.00 am to 5pm during banking hours. However, in the case of e-IPO, the process continues for 24 hours.
BF Biosciences IPO Receives Overwhelming Response from Investors
The book-building phase of BF Biosciences concluded last week with an oversubscription of 3.4 times.
The IPO received an overwhelming response from institutional investors and high-net worth individuals as the strike price clocked in at Rs 77/share, 40 percent higher than the floor price of Rs 55 and raised Rs 1.93 billion.
Shahid Ali, CEO Arif Habib Limited said that investing in the public offering of BF Biosciences presents a decent opportunity for retail investors to engage with a fundamentally strong company at a more attractive valuation compared to the broader pharmaceutical sector.
This unique positioning allows investors to capitalize on potential growth while benefiting from a favorable entry point.
Global perceptions of the US have worsened for the second year running and are now…
Pakistan Armed Forces Release Documentary on Mark-e-Haq Victory A special documentary showcasing modern warfare capabilities…
Shakira Unveils Official Song for 2026 World Cup Colombian singer Shakira announced the official song…
Aga Khan Foundation Pakistan, in partnership with Bank Alfalah, one of the leading commercial banks…
Pakistan Single Window (PSW) and the Trade Development Authority of Pakistan (TDAP) have officially entered…
British health agency identifies additional suspected case of hantavirus The UK Health Security Agency has…
This website uses cookies.
